Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 3,181 | 3,704 | 4,831 | 4,963 | 3,263 |
| Operating Income | -3,181 | -3,704 | -4,831 | -4,963 | -3,263 |
| Other Income | 2,799 | -1,056 | 547 | 1,622 | -792 |
| Pre-tax Income | -382 | -4,760 | -4,284 | -3,341 | -4,055 |
| Income Tax | -1,018 | -605 | -852 | -724 | -889 |
| Net Income Continuous | 636 | -4,155 | -3,432 | -2,617 | -3,166 |
| Net Income | $636 | $-4,155 | $-3,432 | $-2,617 | $-3,166 |
| EPS Basic Total Ops | 0.11 | -0.36 | -0.30 | -0.24 | -0.17 |
| EPS Basic Continuous Ops | 0.11 | -0.36 | -0.30 | -0.24 | -0.17 |
| EPS Diluted Total Ops | 0.11 | -0.36 | -0.30 | -0.24 | -0.17 |
| EPS Diluted Continuous Ops | 0.11 | -0.36 | -0.30 | -0.24 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.26 | -0.33 | -0.24 | N/A |
| EBITDA(a) | $-3,179 | $-3,702 | $-4,829 | $-4,962 | $-3,262 |